Medications for Hypersexuality in Elderly Patients
For elderly patients with hypersexual behavior, SSRIs (sertraline, paroxetine, fluoxetine, citalopram) should be used as first-line pharmacological treatment, starting with low doses and titrating slowly while monitoring for side effects. 1
Assessment Before Treatment
Before initiating medication, evaluate for:
Underlying causes:
- Medication side effects (hormone therapy, opioids)
- Psychological factors (anxiety, depression)
- Cognitive impairment or dementia
- Neurological conditions
Cardiovascular status:
- Essential before hormonal treatments
- Especially important when considering estrogen therapy
Pharmacological Treatment Algorithm
First-Line Treatment:
- SSRIs (sertraline, paroxetine, fluoxetine, citalopram)
Second-Line Treatment:
- Antiandrogens
- Medroxyprogesterone acetate
- Cyproterone acetate
- Consider when SSRIs fail to control behavior 2
Third-Line Treatment:
LHRH agonists (leuprolide, triptorelin)
- Reserved for severe cases resistant to other treatments
- Requires careful medical clearance
Estrogen therapy (including Premarin)
Special Considerations
For Patients with Dementia
- Hypersexual behavior occurs in 3-8% of patients with dementia 3
- Antipsychotics (e.g., risperidone) may be effective when hypersexuality is associated with delirium or psychosis 3
- Consider that hypersexuality may be part of a broader behavioral syndrome in dementia
Cardiovascular Risk
- Cardiovascular assessment is essential before initiating hormonal treatments
- Patients with heart failure should not engage in sexual activity if they have decompensated or advanced (NYHA class III or IV) heart failure until their condition is stabilized 4
Medication Side Effects
- Beta-blockers may contribute to sexual dysfunction (3x risk in some studies) 4
- Consider medication review to identify drugs that might be causing or exacerbating hypersexuality
Treatment Monitoring
- Regular assessment of behavior changes
- Cardiovascular monitoring with hormonal treatments
- Monitoring for feminizing effects with estrogen therapy
- Assessment for adverse effects of medications
Caution
- Combination therapy may be reasonable if monotherapy fails 2
- Limited data exists for treatment of hypersexuality in elderly females
- Evidence for pharmacological management comes primarily from case reports and small case series 2
- Always consider the severity of the behavior and potential risks to the patient and others when selecting treatment intensity